CDC Proposes Doxycycline as STI "Morning After" Pill

The CDC has proposed recommending doxycycline to prevent chlamydia, syphilis and gonorrhea infections after possible exposure.
Doxycycline is currently recommended for high risk individuals like men who have sex with men and transgender women.
It's considered very effective against chlamydia and syphilis but efficacy against gonorrhea varies due to resistance.
Potential side effects include nausea and increased sunburn susceptibility.
Those taking doxycycline should continue STI screening every 3-6 months and be aware of symptoms as it does not prevent viral STIs.